Alexandra Lavalley-Morelle, Ph.D.

Associate Consultant

Portrait-of-Alexandra-Lavelley-Morelle_Pharmetheus

Bio

  • Joined Pharmetheus in 2024, actively working in client projects
  • Expertise includes biostatistics, especially joint modeling of longitudinal and time-to-event data in therapeutic areas such as infectious diseases
  • M.Sc. in Biostatistics (2020) from the National School of Statistics and Data Analysis, France, and Ph.D. in Biostatistics (2023) from Paris Cité University, France
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Exposure-response analysis for time-to-event data in the presence of adaptive dosing: efficient approaches and pitfallsAssessment of Phase 1 pharmacokinetic-pharmacodynamic predictions, based on Phase 3 clinical trials results. Depemokimab pharmacokinetics and response in blood eosinophil count reduction for asthma and chronic rhinosinusitis with nasal polyps patients